Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3403506 | Indian Journal of Tuberculosis | 2015 | 4 Pages |
Abstract
There are limited data of multidrug-resistant tuberculosis (MDR-TB) diagnosed in various patient categories by implementing Programmatic Management of Drug Resistant TB (PMDT) using line probe assay (LPA) from our country. Samples from presumptive MDR-TB from five districts of New Delhi were subjected to LPA from 1st October 2011 to 31st December 2014. The MDR-TB diagnosed in 4th & 5th month follow-up positives were significantly higher than other categories of the patients. Only 3/232 (2.2%) RIF resistants were diagnosed among smear negative re-treatment cases. The data suggest interim cost-benefit analysis of the program especially among smear negatives retreatment cases.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Ritu Singhal, Neeta Singla, Vithal Prasad Myneedu, Niti Singh, Rohit Sarin,